SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-037176
Filing Date
2024-04-29
Accepted
2024-04-29 16:15:29
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0204622-10ka1_180life.htm   iXBRL 10-K/A 394249
2 CERTIFICATION ea020462201ex31-3_180lifesci.htm EX-31.3 3132
3 CERTIFICATION ea020462201ex31-4_180lifesci.htm EX-31.4 3072
4 GRAPHIC image_001.jpg GRAPHIC 4825
  Complete submission text file 0001213900-24-037176.txt   744749

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20231231.xsd EX-101.SCH 3715
6 XBRL DEFINITION FILE atnf-20231231_def.xml EX-101.DEF 19751
7 XBRL LABEL FILE atnf-20231231_lab.xml EX-101.LAB 40059
8 XBRL PRESENTATION FILE atnf-20231231_pre.xml EX-101.PRE 20584
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0204622-10ka1_180life_htm.xml XML 9710
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38105 | Film No.: 24890974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)